Clinical Endpoints and Biomarkers
Cross-source consensus on Clinical Endpoints and Biomarkers from 1 sources and 3 claims.
1 sources · 3 claims
Uses
Comparisons
Highlighted claims
- Clinical endpoints in IRD trials are expanding beyond standard visual acuity to include functional and imaging measures. — Advanced therapeutic approaches for inherited retinal diseases: an umbrella review
- Functional measures and imaging biomarkers are increasingly important because visual acuity alone may miss meaningful changes in mobility, retinal function, and disease progression. — Advanced therapeutic approaches for inherited retinal diseases: an umbrella review
- Deep-learning-based imaging and precise genotyping may enable objective, high-throughput endpoint quantification and improve trial stratification. — Advanced therapeutic approaches for inherited retinal diseases: an umbrella review